Nika Pharmaceuticals, Inc.
NIKA
$0.25
-$0.05-16.67%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -38.48% | -39.23% | -38.27% | 37.96% | 15.98% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -38.48% | -39.23% | -38.27% | 37.96% | 15.98% |
| Operating Income | 38.48% | 39.23% | 38.27% | -37.96% | -15.98% |
| Income Before Tax | 38.48% | 39.23% | 38.27% | -37.96% | -15.98% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 38.48% | 39.23% | 38.27% | -37.96% | -15.98% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 38.48% | 39.23% | 38.27% | -37.96% | -15.98% |
| EBIT | 38.48% | 39.23% | 38.27% | -37.96% | -15.98% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 100.00% | 100.00% | 100.00% | -- | -- |
| Normalized Basic EPS | -- | -- | -- | -- | -- |
| EPS Diluted | 100.00% | 100.00% | 100.00% | -- | -- |
| Normalized Diluted EPS | -- | -- | -- | -- | -- |
| Average Basic Shares Outstanding | 8.83% | 12.49% | 16.84% | 12.55% | -0.71% |
| Average Diluted Shares Outstanding | 8.83% | 12.49% | 16.84% | 12.55% | -0.71% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |